Stockreport

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury [Yahoo! Finance]

Alpha Cognition Inc.  (ACOG) 
PDF the "Company"), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced interim preclinical data that suppor [Read more]